ClinConnect ClinConnect Logo
Search / Trial NCT06292156

tACS Treatment for Cognitive Impairments in Methamphetamine Addicts

Launched by BEIJING HUILONGGUAN HOSPITAL · Mar 2, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Methamphetamine Patients Cognitive Impairments T Acs

ClinConnect Summary

This clinical trial is studying the effects of a treatment called transcranial alternating current stimulation (tACS) on people who have cognitive impairments due to methamphetamine use. The goal is to understand how methamphetamine affects brain function and to see if tACS can help improve thinking and memory skills in these patients. Researchers are currently looking for participants aged 18 to 65 who have a specific diagnosis of methamphetamine use disorder and do not have any other drug use, serious health issues, or mental illnesses.

If you or someone you know is eligible and decides to participate, you can expect to undergo some assessments to evaluate cognitive function and possibly receive the tACS treatment. This non-invasive treatment involves using a device that delivers a mild electrical current to the scalp, which aims to enhance brain activity. Participating in this trial could help you gain a better understanding of the impact of methamphetamine on your cognitive abilities and explore a potential new way to improve them.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis diagnosis of methamphetamine use disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • None of participants had mixed use of other drugs
  • None of participants had physical disability
  • None of participants had acute physical or mental illness, hallucinations, acute withdrawal symptoms
  • None of participants were receiving any medical treatment
  • Exclusion Criteria:
  • Intracranial hypertension
  • Cranial defects
  • Tumors
  • Serious physical illnesses (e.g., cardiovascular, liver, kidney, gastrointestinal disorders)
  • Infectious diseases
  • Immune system disorders

About Beijing Huilongguan Hospital

Beijing Huilongguan Hospital is a leading medical institution in China, dedicated to providing advanced healthcare services and pioneering research in clinical medicine. With a strong emphasis on mental health and comprehensive patient care, the hospital is at the forefront of innovative treatment methodologies and clinical trials. As a sponsor of clinical research, Beijing Huilongguan Hospital collaborates with renowned experts and utilizes state-of-the-art facilities to facilitate the development of effective therapeutic interventions, contributing to the global body of medical knowledge and improving patient outcomes.

Locations

Mianyang, , China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported